2001 related articles for article (PubMed ID: 31347678)
1. Obstetric and neonatal outcome of ART in patients with polycystic ovary syndrome: IVM of oocytes versus controlled ovarian stimulation.
Mostinckx L; Segers I; Belva F; Buyl R; Santos-Ribeiro S; Blockeel C; Smitz J; Anckaert E; Tournaye H; De Vos M
Hum Reprod; 2019 Aug; 34(8):1595-1607. PubMed ID: 31347678
[TBL] [Abstract][Full Text] [Related]
2. Growth and other health outcomes of 2-year-old singletons born after IVM versus controlled ovarian stimulation in mothers with polycystic ovary syndrome.
Belva F; Roelants M; Vermaning S; Desmyttere S; De Schepper J; Bonduelle M; Tournaye H; Hes F; De Vos M
Hum Reprod Open; 2020; 2020(1):hoz043. PubMed ID: 32055712
[TBL] [Abstract][Full Text] [Related]
3. An improved IVM method for cumulus-oocyte complexes from small follicles in polycystic ovary syndrome patients enhances oocyte competence and embryo yield.
Sánchez F; Lolicato F; Romero S; De Vos M; Van Ranst H; Verheyen G; Anckaert E; Smitz JEJ
Hum Reprod; 2017 Oct; 32(10):2056-2068. PubMed ID: 28938744
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation and mRNA expression of imprinted genes in blastocysts derived from an improved in vitro maturation method for oocytes from small antral follicles in polycystic ovary syndrome patients.
Saenz-de-Juano MD; Ivanova E; Romero S; Lolicato F; Sánchez F; Van Ranst H; Krueger F; Segonds-Pichon A; De Vos M; Andrews S; Smitz J; Kelsey G; Anckaert E
Hum Reprod; 2019 Sep; 34(9):1640-1649. PubMed ID: 31398248
[TBL] [Abstract][Full Text] [Related]
5. Positive effects of amphiregulin on human oocyte maturation and its molecular drivers in patients with polycystic ovary syndrome.
Akin N; Le AH; Ha UDT; Romero S; Sanchez F; Pham TD; Nguyen MHN; Anckaert E; Ho TM; Smitz J; Vuong LN
Hum Reprod; 2021 Dec; 37(1):30-43. PubMed ID: 34741172
[TBL] [Abstract][Full Text] [Related]
6. In-vitro maturation of oocytes versus conventional IVF in women with infertility and a high antral follicle count: a randomized non-inferiority controlled trial.
Vuong LN; Ho VNA; Ho TM; Dang VQ; Phung TH; Giang NH; Le AH; Pham TD; Wang R; Smitz J; Gilchrist RB; Norman RJ; Mol BW
Hum Reprod; 2020 Nov; 35(11):2537-2547. PubMed ID: 32974672
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes from ART in predicted hyperresponders: in vitro maturation of oocytes versus conventional ovarian stimulation for IVF/ICSI.
Mostinckx L; Goyens E; Mackens S; Roelens C; Boudry L; Uvin V; Segers I; Schoemans C; Drakopoulos P; Blockeel C; De Vos M
Hum Reprod; 2024 Mar; 39(3):586-594. PubMed ID: 38177084
[TBL] [Abstract][Full Text] [Related]
8. Reproductive hormones of ICSI-conceived young adult men: the first results.
Belva F; Roelants M; De Schepper J; Van Steirteghem A; Tournaye H; Bonduelle M
Hum Reprod; 2017 Feb; 32(2):439-446. PubMed ID: 28007789
[TBL] [Abstract][Full Text] [Related]
9. Semen quality of young adult ICSI offspring: the first results.
Belva F; Bonduelle M; Roelants M; Michielsen D; Van Steirteghem A; Verheyen G; Tournaye H
Hum Reprod; 2016 Dec; 31(12):2811-2820. PubMed ID: 27707840
[TBL] [Abstract][Full Text] [Related]
10. The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF.
Massin N; Abdennebi I; Porcu-Buisson G; Chevalier N; Descat E; Piétin-Vialle C; Goro S; Brussieux M; Pinto M; Pasquier M; Bry-Gauillard H
Hum Reprod; 2023 May; 38(5):927-937. PubMed ID: 36864699
[TBL] [Abstract][Full Text] [Related]
11. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
[TBL] [Abstract][Full Text] [Related]
12. Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial.
Griesinger G; Blockeel C; Sukhikh GT; Patki A; Dhorepatil B; Yang DZ; Chen ZJ; Kahler E; Pexman-Fieth C; Tournaye H
Hum Reprod; 2018 Dec; 33(12):2212-2221. PubMed ID: 30304457
[TBL] [Abstract][Full Text] [Related]
13. Human cumulus-enclosed germinal vesicle oocytes from early antral follicles reveal heterogeneous cellular and molecular features associated with in vitro maturation capacity.
Sánchez F; Romero S; De Vos M; Verheyen G; Smitz J
Hum Reprod; 2015 Jun; 30(6):1396-409. PubMed ID: 25904637
[TBL] [Abstract][Full Text] [Related]
14. Birthweight and other perinatal outcomes of singletons conceived after assisted reproduction compared to natural conceived singletons in couples with unexplained subfertility: follow-up of two randomized clinical trials.
Wessel JA; Mol F; Danhof NA; Bensdorp AJ; Tjon-Kon Fat RI; Broekmans FJM; Hoek A; Mol BWJ; Mochtar MH; van Wely M;
Hum Reprod; 2021 Feb; 36(3):817-825. PubMed ID: 33347597
[TBL] [Abstract][Full Text] [Related]
15. Neonatal health including congenital malformation risk of 1072 children born after vitrified embryo transfer.
Belva F; Bonduelle M; Roelants M; Verheyen G; Van Landuyt L
Hum Reprod; 2016 Jul; 31(7):1610-20. PubMed ID: 27165622
[TBL] [Abstract][Full Text] [Related]
16. Early pregnancy loss in patients with polycystic ovary syndrome after IVM versus standard ovarian stimulation for IVF/ICSI.
Mackens S; Mostinckx L; Drakopoulos P; Segers I; Santos-Ribeiro S; Popovic-Todorovic B; Tournaye H; Blockeel C; De Vos M
Hum Reprod; 2020 Dec; 35(12):2763-2773. PubMed ID: 33025015
[TBL] [Abstract][Full Text] [Related]
17. ESHRE guideline: ovarian stimulation for IVF/ICSI
Ovarian Stimulation TEGGO; Bosch E; Broer S; Griesinger G; Grynberg M; Humaidan P; Kolibianakis E; Kunicki M; La Marca A; Lainas G; Le Clef N; Massin N; Mastenbroek S; Polyzos N; Sunkara SK; Timeva T; Töyli M; Urbancsek J; Vermeulen N; Broekmans F
Hum Reprod Open; 2020; 2020(2):hoaa009. PubMed ID: 32395637
[TBL] [Abstract][Full Text] [Related]
18. In vitro maturation as an alternative to standard in vitro fertilization for patients diagnosed with polycystic ovaries: a comparative analysis of fresh, frozen and cumulative cycle outcomes.
Walls ML; Hunter T; Ryan JP; Keelan JA; Nathan E; Hart RJ
Hum Reprod; 2015 Jan; 30(1):88-96. PubMed ID: 25355587
[TBL] [Abstract][Full Text] [Related]
19. Outcome of in-vitro oocyte maturation in patients with PCOS: does phenotype have an impact?
Mackens S; Pareyn S; Drakopoulos P; Deckers T; Mostinckx L; Blockeel C; Segers I; Verheyen G; Santos-Ribeiro S; Tournaye H; De Vos M
Hum Reprod; 2020 Oct; 35(10):2272-2279. PubMed ID: 32951028
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the obstetric and perinatal outcomes of children conceived from in vitro or in vivo matured oocytes in in vitro maturation treatments with births from conventional ICSI cycles.
Fadini R; Mignini Renzini M; Guarnieri T; Dal Canto M; De Ponti E; Sutcliffe A; Shevlin M; Comi R; Coticchio G
Hum Reprod; 2012 Dec; 27(12):3601-8. PubMed ID: 23042796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
